Miromatrix Medical Inc.
MIRODelisted Dec 13, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001527096
Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Miromatrix Medical Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −2 vs. Q2 2021
- Shares held
- 3.16M
- −201.7K (−6.0%) vs. Q2 2021
- Total value
- $22.0M
- −$17.2M (−43.9%) vs. Q2 2021
- New holders
- 6
- 3 more added
- Sold out
- 8
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 32 | $8.78M |
| Q2 2023 | 32 | $11.6M |
| Q1 2023 | 31 | $11.1M |
| Q4 2022 | 28 | $11.2M |
| Q3 2022 | 22 | $15.4M |
| Q2 2022 | 22 | $12.9M |
| Q1 2022 | 21 | $12.6M |
| Q4 2021 | 22 | $14.5M |
| Q3 2021 | 19 | $22.0M |
| Q2 2021 | 21 | $39.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Miromatrix Medical Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| G2 Investment Partners Management LLC | 679,970 | $4.73M | 0.82% | +70,850+11.6% | Added |
| First Light Asset Management, LLC | 475,000 | $3.31M | 0.22% | 00.0% | Unchanged |
| Gagnon Securities LLC | 423,549 | $2.95M | 0.44% | −12,360−2.8% | Reduced |
| Polar Asset Management Partners Inc. | 300,000 | $2.09M | 0.02% | 00.0% | Unchanged |
| RTW Investments, LP | 280,000 | $1.95M | 0.03% | 00.0% | Unchanged |
| Friess Associates LLC | 246,323 | $1.71M | 0.72% | +26,323+12.0% | Added |
| Gagnon Advisors, LLC | 229,802 | $1.60M | 0.63% | 00.0% | Unchanged |
| Granite Point Capital Management, L.P. | 177,642 | $1.24M | 0.48% | −30,897−14.8% | Reduced |
| AWM Investment Company, Inc. | 116,688 | $812.0K | 0.08% | +1,688+1.5% | Added |
| Manatuck Hill Partners, LLC | 83,042 | $578.0K | 0.20% | −16,958−17.0% | Reduced |
| Perkins Capital Management Inc | 47,220 | $329.0K | 0.20% | −2,780−5.6% | Reduced |
| Millennium Management LLC | 44,315 | $308.0K | 0.00% | −11,850−21.1% | Reduced |
| Jane Street Group, LLC | 23,483 | $163.0K | 0.00% | −16,358−41.1% | Reduced |
| BlackRock Inc. | 14,786 | $103.0K | 0.00% | +14,786 | New |
| Geode Capital Management, LLC | 10,203 | $71.0K | 0.00% | +10,203 | New |
| Royal Bank of Canada | 2,000 | $14.0K | 0.00% | +2,000 | New |
| Tower Research Capital LLC (TRC) | 1,309 | $9.00K | 0.00% | +1,309 | New |
| UBS Group AG | 125 | $1.00K | 0.00% | +125 | New |
| Wells Fargo & Company | 29 | $0 | 0.00% | +29 | New |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −160,000−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −19,365−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,467−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Essex Investment Management Co LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,126−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −900−100.0% | Sold out |